dictator 发表于 2025-3-30 09:16:01
http://reply.papertrans.cn/95/9417/941668/941668_51.png审问 发表于 2025-3-30 15:15:33
http://reply.papertrans.cn/95/9417/941668/941668_52.pngMerited 发表于 2025-3-30 18:48:03
Derek SewardsAML) and are characterized by distinct historical, clinical, and molecular features that distinguish them from de novo AML. AML-MRC and t-AML patients tend to be older and more frequently harbor adverse cytogenetic features such as complex or monosomal karyotypes and high-risk mutations (e.g., .) l